US PBM Reform: ‘Bust Them Up’ A Theme For 2025?

A House Committee on Oversight and Accountability hearing on potential PBM reform legislation suggests there remains strong, bipartisan interest in crafting legislation that could have a significant impact on the sector, but also that any substantive actions will not come before next year.

The committee heard testimony from executives of the “big three” pharmacy benefit management companies, CVS Caremark, Express Scripts and United/Optum Rx, at its July 23 hearing on “transparency and accountability.” The hearing was the third in a series from the committee after previous sessions were held in May and September 2023.